Publications by authors named "A A Al Bshabshe"
Dengue fever, caused by the dengue virus and transmitted through Aedes mosquitoes, is a growing public health concern, particularly in tropical and subtropical regions. Traditionally associated with febrile and hemorrhagic symptoms, recent research suggests a potential link between dengue and cognitive impairments. This systematic review assessed existing research to understand the association between dengue virus infection and cognitive impairments, including dementia, Alzheimer disease, memory loss, and confusion.
View Article and Find Full Text PDFBackground: The diagnostic performance of the available risk assessment models for VTE in patients who are critically ill receiving pharmacologic thromboprophylaxis is unclear.
Research Question: For patients who are critically ill receiving pharmacologic thromboprophylaxis, do risk assessment models predict who would develop VTE or who could benefit from adjunctive pneumatic compression for thromboprophylaxis?
Study Design And Methods: In this post hoc analysis of the Pneumatic Compression for Preventing VTE (PREVENT) trial, different risk assessment models for VTE (ICU-VTE, Kucher, Intermountain, Caprini, Padua, and International Medical Prevention Registry on VTE [IMPROVE] models) were evaluated. Receiver-operating characteristic curves were constructed, and the sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios were calculated.
Introduction: The Enterococcus genus is a common cause of nosocomial infections, with vancomycin-resistant enterococci (VRE) posing a significant treatment challenge.
Method: This retrospective study, spanning ten years (2012 to 2021), analyzes antimicrobial susceptibility patterns of species from clinical samples in a Saudi Arabian tertiary care hospital.
Result: A total of 1034 Enterococcus isolates were collected, 729 from general wards and 305 from intensive care unit (ICU) patients.
Article Synopsis
- The REPLENISH trial aims to determine if higher protein supplementation in critically ill patients improves 90-day survival rates compared to moderate protein intake.
- The study will involve randomizing 2,502 mechanically ventilated patients to receive either higher (2-2.4 g/kg/day) or moderate (0.8-1.2 g/kg/day) protein levels, with a focus on all-cause mortality and quality of life outcomes.
- The research has received ethical approval and will share findings through journals and conferences to influence future clinical practices.
Pituitary apoplexy is a major complication of pituitary adenoma, and the diagnosis might be challenging if the patient presents with signs of meningeal irritation or electrolyte imbalance. It can be fatal if not diagnosed and treated appropriately. Apoplexy is the first clinical presentation in the majority of pituitary adenoma cases.
View Article and Find Full Text PDF